Phase IV Clinical Trial of an Influenza Split Vaccine Anflu

NCT00556062 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

566

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: seasonal split influenza vaccine
BIOLOGICAL: seasonal split influenza vaccine
BIOLOGICAL: seasonal split influenza vaccine
BIOLOGICAL: seasonal split influenza vaccine

Sponsor

Sinovac Biotech Co., Ltd